Presenting Education Outcomes at ASPHO 2022
We're pleased to share that the conference has accepted our poster abstract "Impact of Patient-Provider Initiative on Treatment of Pediatric Neuroblastoma" at the 2022 American Society of Pediatric Hematology/Oncology (ASPHO) Conference brings together hematology/oncology professionals for premier education and networking. Read More
ASGCT Partners with PlatformQ Health to Bring Impactful, Timely Gene and Cell Therapy Digital Education to Providers and Patients
May 3, 2022 – The American Society of Gene and Cell Therapy (ASGCT) has formed a strategic alliance with the digital technology and education company PlatformQ Health to deliver in-depth digital education programs for clinicians as well as patients and families. Read More
CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy Treatment
The initiative succeeded in improving clinicians' understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. Read More
2022 Alliance Industry Summit Supplemental Digital Resources
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will Read More
A collaborative approach to digital neurology education
Together with leading advocacy organizations, we’ve created unique learning channels that help make a difference in the lives of patients with conditions such as multiple sclerosis, dementia, and many other neurological conditions. Read More
Spring Partnership Newsletter – The latest from medical education thought leaders
Spring is here and we are excited to share some of our latest articles and webinars that explore pressing medical education and healthcare topics that you may be interested in. Read More
Presenting Educational Outcomes in Migraine, SMA and Insomnia at AAN
PlatformQ Health is proud to be presenting three posters in Migraine, SMA and Insomnia at the American Academy of Neurology's Annual 2022 Meeting. Read More
KDIGO Advocates for Multidisciplinary Patient Care
“CKD is a silent disease,” said Cheung. “There is significant under-recognition that people may have it. That’s really unfortunate because there are effective therapies, ranging from renin-angiotensin system inhibitors to statins. Read More
A True Champion: A conversation with powerhouse Ricki Fairley
Hear from 10-year cancer survivor, influential advocate and TOUCH CEO, Ricki Fairley, as she dispels myths around clinical trials and discusses how to drive more equitable trial enrollment. Read More
CME Palooza Spotlight: Equity in Clinical Trials Is Within Reach: Patient Voices in Medical Education Matter
In our latest collaboration with CME Palooza, we hosted a webinar featuring Jeanne Regnante, Chief Health Equity and Diversity Officer of the lung cancer advocacy organization, LUNGevity, Shawn Feliciano, a Read More
Diversity in Rare Disease Clinical Trials: Making meaningful & practical changes
Leaders from the Moffitt Cancer Center, NORD and TOUCH speak on behalf of their organizations about what they are doing in their day to day to make a difference in the lives of Black or other underserved patient populations. Read More
Winter Newsletter – Sharing the latest in partnerships news
Education is at the heart of everything — from launching new screening protocols, to releasing new medications, to enhancing patients’ quality of life. As we enter the New Year, our CEO, Robert Rosenbloom took the time to reflect back on 2021 and impact we’ve had on patients, clinicians and caregivers. Read More
